GAT Values More Discordant Than DCT Measures in Glaucoma

Share this content:
GAT Values More Discordant Than DCT Measures in Glaucoma
GAT Values More Discordant Than DCT Measures in Glaucoma

WEDNESDAY, May 17, 2017 (HealthDay News) -- Conventional Goldmann applanation tonometry (GAT) values for intraocular pressure (IOP) are significantly discordant compared with Pascal dynamic contour tonometry (DCT) measurements in patients with thin corneas and advanced glaucoma, according to a study published online May 11 in JAMA Ophthalmology.

Josephine Wachtl, from the University Hospital Zurich, and colleagues conducted a prospective cross-sectional case series among 112 white patients with glaucoma. The authors performed IOP measurements with GAT and DCT and examined the difference between corrected and conventional GAT and DCT measurements.

The researchers found that the mean IOP was 20.3 and 17.0 mm Hg as measured by DCT and GAT, respectively, with a mean discordance between measures of −3.3 mmHg. Compared with DCT, the five corrected GAT values ranged from −2.7 to −5.4 mm Hg. The mean result of the Dresdner correction formula was 17.6 mm Hg, which was closer to the DCT than the GAT measurement. There was a mean Glaucoma Severity Score of 4.7. A positive correlation was seen for uncorrected discordance (IOPDCT − IOPGAT) with the Glaucoma Severity Score (rs = 0.33), and a negative correlation with central corneal thickness (rs = −0.22).

"Application of GAT-based correction formulas involves a possible risk of creating an even greater number of unpredictable measurement errors," the authors write. "Hence, we advise with caution, especially pertaining to eyes with thin corneas, to not place reliance on GAT readings, and abandon any correction formula."

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »